期刊文献+

毛细血管内增生性肾炎致肾病综合征的激素治疗作用 被引量:13

Effect of glucocorticoid on nephrotic syndrome from endocapillary proliferative glomerulonephritis
原文传递
导出
摘要 目的探讨糖皮质激素(GC)对毛细血管内增生性肾炎(EPGN)致肾病综合征(NS)的治疗作用。方法采取开放对照研究,对9例EPGN性NS,病程4周无好转的患者,给予大剂量标准疗程的强的松治疗,治疗结果与常规治疗组进行对比。结果强的松组9例中,治疗2个月后7例获得完全缓解(77.8%),12个月后9例全部达到完全缓解(100%)。常规治疗组10例中,在相应时间观察到的完全缓解人数分别为2例(20.0%)和5例(50.0%),两组间两个时期完全缓解率均有显著性差异(P<0.05)。结论对EPGN性NS,使用强的松治疗可以有效地减少蛋白尿,使患者早日达到完全缓解。 bjective To identify the effect of glucocorticoid(GC) on the nephrotic syndrome(NS) from endocapillary proliferative glomerulonephritis(EPGN). Methods An open, contrasted study was conducted. Cases with NS from EPGN were divided into two groups, one of them was treated with conventional therapy and another one with a large dose of prednisone based on conventional way. The result was compared and analysed. Results The total number of entirely remission was 7 cases(77.8%) within two months and 9 cases(100%) within 12 months after treatment in prednisone group. Compared with 2 cases(20%) and 5 cases(50%) in control group, the difference of entirely remissiom rate was statistically significant. Conclusion Prednisone is effective on the NS from EPGN to reduce proteinuria and make entirely remission earlier.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 1999年第3期155-157,共3页 Chinese Journal of Nephrology
关键词 肾病综合征 肾小球肾炎 糖皮质激素 药物疗法 Nephrotic syndromeGlomerulonephritisGlucocorticoid
  • 相关文献

参考文献4

  • 1吴燕祥 彭燕 等.小儿毛细血管内增生性肾炎临床和病理分析[J].中华肾脏病杂志,1998,6:199-200.
  • 2吴燕祥,中华肾脏病杂志,1998年,6期,199页
  • 3王海燕,肾脏病学(第2版),1996年,610页
  • 4叶任高,肾脏病诊断与治疗学,1994年,220页

共引文献6

同被引文献66

  • 1沈颖,樊剑锋.急性链球菌感染后肾小球肾炎[J].临床儿科杂志,2006,24(6):457-459. 被引量:20
  • 2罗晓菊,刘雪梅,豆虎.急性肾小球肾炎与肾病综合征患儿体液免疫指标比较[J].实用儿科临床杂志,2007,22(5):363-364. 被引量:7
  • 3闵月,宋晓翔,倪征,程江,封其华,李晓忠.毛细血管内增生性肾炎致肾病综合征6例临床分析[J].中国实用儿科杂志,2007,22(5):355-357. 被引量:8
  • 4邹尤忠.关于原发性肾小球疾病的病理类型及命名的建议[J].中华肾脏病杂志,1986,2:172-173.
  • 5吴燕祥 彭燕 等.小儿毛细血管内增生性肾炎临床和病理分析[J].中华肾脏病杂志,1998,6:199-200.
  • 6Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases : Renoprotective benefits of rennin - angiotensin system inhibitin. Ann Intern Med ,2002,136:604 - 615.
  • 7Weir MR. Progressive renal and eardiovaseular disease : Optimal treatment strategies. Kidney Int ,2002,62:1482 -1492.
  • 8Sehieppatti A, Remuzzi G: The future of renoprotection: Frustrations and promises. Kidney Int, 2004,64 : 1974 - 1955.
  • 9Nakao N, Yoshimura A, Morita H, et al. Combination treatment of an -giotensin - Ⅱ Receptor blocker and angiotensin - converting enzyme inhibitor in non - diabetec renal disease (COOPERATE) : A randomized controlled trisl. LANCET 2003,361 : 117 - 124.
  • 10Pedro Aranda, Julian Segura, Lois M, et al. Longterm Renoprotectire Effects of Standard Versus High Doses of Telmisartan in Hypertensive Nondiabetic Nephropathies. AM J Kidney Dis,2005,46:1074 - 1079.

引证文献13

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部